Vivo Capital

Vivo Capital as of Sept. 30, 2023

Portfolio Holdings for Vivo Capital

Vivo Capital holds 53 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Genetron Holdings Ads 11.5 $105M 8.1M 12.87
Soleno Therapeutics Common (SLNO) 10.4 $95M 3.2M 29.51
Harmony Biosciences Holdings Common (HRMY) 9.4 $85M 2.6M 32.77
Verona Pharma Ads (VRNA) 7.6 $69M 4.2M 16.30
Avadel Pharmaceuticals Adr (AVDL) 4.6 $42M 4.1M 10.30
Tarsus Pharmaceuticals Common (TARS) 4.4 $40M 2.3M 17.77
Sinovac Biotech SHS (SVA) 4.2 $38M 5.9M 6.47
Geron Corp Common (GERN) 3.8 $35M 17M 2.12
Terns Pharmaceuticals Common (TERN) 3.7 $34M 6.7M 5.03
Gracell Biotechnologies Sponsored Ads 3.4 $31M 11M 2.88
Viridian Therapeutics Common (VRDN) 2.8 $26M 1.7M 15.34
Olema Pharmaceuticals Common (OLMA) 2.5 $23M 1.9M 12.35
Cogent Biosciences Common (COGT) 2.4 $22M 2.2M 9.75
ALX Oncology Holdings Common (ALXO) 2.2 $20M 4.2M 4.80
Arcellx Common (ACLX) 2.0 $18M 504k 35.88
Ventyx Biosciences Common (VTYX) 1.6 $15M 422k 34.73
Rayzebio Common 1.5 $14M 634k 22.20
Icosavax Common 1.4 $13M 1.7M 7.75
Astria Therapeutics Common (ATXS) 1.4 $13M 1.7M 7.46
Verastem Common (VSTM) 1.4 $13M 1.5M 8.13
Compass Pathway Sponsored Ads (CMPS) 1.3 $12M 1.6M 7.40
Zai Lab Adr (ZLAB) 1.2 $11M 455k 24.31
Alpine Immune Sciences Common (ALPN) 1.1 $11M 915k 11.45
Crinetics Pharmaceuticals Common (CRNX) 1.1 $10M 350k 29.74
Dyne Therapeutics Common (DYN) 1.0 $9.3M 1.0M 8.96
IO Biotech Common (IOBT) 1.0 $8.7M 6.2M 1.41
Apogee Therapeutics Common (APGE) 0.9 $8.5M 400k 21.30
KalVista Pharmaceuticals Common (KALV) 0.9 $8.2M 856k 9.63
Delcath Systems Common (DCTH) 0.8 $7.5M 1.9M 4.05
Savara Common (SVRA) 0.8 $7.2M 1.9M 3.78
Compass Therapeutics Common (CMPX) 0.8 $7.0M 3.6M 1.97
Allakos Common (ALLK) 0.7 $6.8M 3.0M 2.27
Aadi Bioscience Common (AADI) 0.7 $6.5M 510k 12.67
Aclaris Therapeutics Common (ACRS) 0.7 $6.2M 899k 6.85
Instil Bio Common 0.6 $5.3M 13M 0.43
Oric Pharmaceuticals Common (ORIC) 0.5 $4.7M 778k 6.05
Bolt Therapeutics Common (BOLT) 0.4 $4.0M 3.9M 1.04
Arrowhead Pharmaceuticals Common (ARWR) 0.4 $3.7M 137k 26.87
DBV Technologies SA Sponsored ADR (DBVT) 0.4 $3.7M 2.7M 1.36
Sera Prognostics Common (SERA) 0.4 $3.5M 1.9M 1.86
Unicycive Therapeutics Common (UNCY) 0.3 $3.0M 3.5M 0.86
Iovance Biotherapeutics Common (IOVA) 0.3 $3.0M 655k 4.55
Aligos Therapeutics Common (ALGS) 0.3 $2.6M 3.5M 0.75
Fulcrum Therapeutics Common (FULC) 0.3 $2.3M 520k 4.44
Clene Common (CLNN) 0.2 $1.4M 2.6M 0.53
Impel NeuroPharma Common (IMPLQ) 0.1 $1.2M 2.9M 0.43
Aslan Pharmaceuticals Ads 0.1 $1.1M 568k 1.88
BioAtla Common (BCAB) 0.1 $908k 534k 1.70
Codexis Common (CDXS) 0.1 $734k 388k 1.89
Rezolute Common (RZLT) 0.1 $640k 484k 1.32
Amyris Common (AMRSQ) 0.1 $465k 7.8M 0.06
Homology Medicines Common 0.0 $433k 370k 1.17
Precision Biosciences Common 0.0 $48k 140k 0.34